BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 19261354)

  • 1. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
    Cunha-Júnior JP; Silva DA; Silva NM; Souza MA; Souza GR; Prudencio CR; Pirovani CP; Cezar M Cascardo J; Barbosa BF; Goulart LR; Mineo JR
    Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies.
    Béla SR; Oliveira Silva DA; Cunha-Júnior JP; Pirovani CP; Chaves-Borges FA; Reis de Carvalho F; Carrijo de Oliveira T; Mineo JR
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):245-54. PubMed ID: 18703303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
    Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
    J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera.
    Carvalho FR; Silva DA; Cunha-Júnior JP; Souza MA; Oliveira TC; Béla SR; Faria GG; Lopes CS; Mineo JR
    Clin Vaccine Immunol; 2008 Aug; 15(8):1265-71. PubMed ID: 18562566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites.
    Zhang H; Compaore MK; Lee EG; Liao M; Zhang G; Sugimoto C; Fujisaki K; Nishikawa Y; Xuan X
    Mol Biochem Parasitol; 2007 Feb; 151(2):205-12. PubMed ID: 17156863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice.
    Zhang G; Huang X; Boldbaatar D; Battur B; Battsetseg B; Zhang H; Yu L; Li Y; Luo Y; Cao S; Goo YK; Yamagishi J; Zhou J; Zhang S; Suzuki H; Igarashi I; Mikami T; Nishikawa Y; Xuan X
    Vaccine; 2010 Oct; 28(45):7243-7. PubMed ID: 20832493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody directed against Neospora caninum tachyzoite carbohydrate epitope reacts specifically with apical complex-associated sialylated beta tubulin.
    Srinivasan S; Baszler T; Vonlaufen N; Leepin A; Sanderson SJ; Wastling JM; Hemphill A
    J Parasitol; 2006 Dec; 92(6):1235-43. PubMed ID: 17304800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.
    Macêdo AG; Cunha JP; Cardoso TH; Silva MV; Santiago FM; Silva JS; Pirovani CP; Silva DA; Mineo JR; Mineo TW
    Parasit Vectors; 2013 Jun; 6():163. PubMed ID: 23735002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30).
    Mineo JR; Kasper LH
    Exp Parasitol; 1994 Aug; 79(1):11-20. PubMed ID: 8050521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route.
    Mévélec MN; Mercereau-Puijalon O; Buzoni-Gatel D; Bourguin I; Chardès T; Dubremetz JF; Bout D
    Parasite Immunol; 1998 Apr; 20(4):183-95. PubMed ID: 9618729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
    Rodriguez C; Afchain D; Capron A; Dissous C; Santoro F
    Eur J Immunol; 1985 Jul; 15(7):747-9. PubMed ID: 2408905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.
    Yang D; Liu J; Hao P; Wang J; Lei T; Shan D; Liu Q
    Parasitol Res; 2015 Oct; 114(10):3791-9. PubMed ID: 26141436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SRS superfamily of Toxoplasma surface proteins.
    Jung C; Lee CY; Grigg ME
    Int J Parasitol; 2004 Mar; 34(3):285-96. PubMed ID: 15003490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis.
    Zhang H; Lee EG; Liao M; Compaore MK; Zhang G; Kawase O; Fujisaki K; Sugimoto C; Nishikawa Y; Xuan X
    Mol Biochem Parasitol; 2007 Jun; 153(2):141-8. PubMed ID: 17412435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.